An early-stage clinical trial of an unusual experimental malaria vaccine shows it is safe, generates an immune response, and may provide 100% protection against malaria infection in healthy adults, the best result for a malaria vaccine so far. The trial tested the PfSPZ vaccine, developed by Sanaria Inc of Rockville, Maryland, in the US...
More...
More...